financial estimates

NeoGenomics Stock Plummets on Predicted Lower Q1 Expectations, Departure of CEO

Biodesix Q4 Revenues Decline 73 Percent on Drop in COVID-19 Testing

Siemens Healthineers Fiscal Q1 Dx Revenues Rise 23 Percent on COVID-19 Rapid Antigen Test Demand

Quanterix Projects Q4 2021 Revenues of $29M to $31M

Accelerate Diagnostics CEO Lays Out Plans at JP Morgan Healthcare Conference

Danaher, PerkinElmer, Cue Health, Others Announce Preliminary Q4 Earnings Results

Exact Sciences Projects up to $475M in Q4 Revenues, Acquires Testing Lab, Inks Licensing Deal

Quidel Preliminary Q4 Revenues Drop 21 Percent, Beat Estimates

Quidel Preliminary Q3 Revenues Rise, Easily Beat Analysts' Estimate

Chembio Diagnostics Q2 Revenues Rise 27 Percent; Firm Conducts Going Concern Evaluation

PerkinElmer to Acquire BioLegend for $5.25B; Q2 Revenues Rise 51 Percent

Natera Reports Preliminary Q2 Revenue Growth of Around 60 Percent

Meridian Bioscience Fiscal Q3 Preliminary Revenues Drop 25 Percent

Qiagen Reports Preliminary Q2 Revenues Above Guidance; Adjusts FY21 Expectations Downward

Ortho Clinical Diagnostics Q1 Revenues Rise 24 Percent on Core Revenue Strength

Quidel Preliminary Q1 Revenues Double But Fall Far Short of Expectations

HTG Molecular Preliminary Q1 Revenues Fall 56 Percent

360Dx Index Declines 2 Percent in March, Continuing Downward Slope